Back to top

Regeneron posts Q2 beat as new Eylea version outperforms

Regeneron posts Q2 beat as new Eylea version outperforms

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Bayer Aktiengesellschaft (BAYRY)

Novo Nordisk A/S (NVO)

Regeneron Pharmaceuticals, Inc. (REGN)

Sanofi (SNY)